Newsroom

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the first quarter 2026 on Wednesday, May 13, 2026 after market close. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss recent developments and highlights as well as the Company’s financial results. Conference Call Details and Webcast Link Instructions To access the live webcast, please click...

GLEN ALLEN, Va.--(BUSINESS WIRE)--Dynex Capital, Inc. (NYSE: DX), a REIT with a long track record of generating dividends from high-quality mortgage assets, announced today that the Company’s Board of Directors has declared a cash dividend of $0.17 per share on its Common Stock for May 2026. The dividend is payable on June 1, 2026, to shareholders of record as of May 21, 2026. About Dynex Capital Dynex Capital, Inc. (NYSE: DX) is a leading internally managed REIT with a long track record of del...

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to five newly hired non-executive employees consisting of options to purchase an aggregate of 255,340 common shares of the Company (the "Options") with effective grant dates of April 27, 202...

NEW YORK--(BUSINESS WIRE)--AlTi Global, Inc. (NASDAQ: ALTI) (“AlTi” or the “Company”), a leading independent global wealth manager with $90 billion in assets, today announced financial results for the first quarter ended March 31, 2026. A presentation of the Company’s results for the first quarter ended March 31, 2026 can be found on the Events & Presentations section of the AlTi investor relations website. Webcast and Earnings Conference Call Management will host a webcast and conference c...

IRVING, Texas--(BUSINESS WIRE)--Nexstar Media Group names Elizabeth Ryder EVP, General Counsel and Secretary of the Board of Directors and announces three other executive promotions....

DALLAS--(BUSINESS WIRE)--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the issuance of equity inducement awards as required by the Nasdaq Stock Market Rules. In accordance with NASDAQ Listing Rule 5635(c)(4), the Compensation Committee of Forte’s Board of Directors approved the grant of equity awards in the form of options to purchase a total of 50,000 shares of its c...

WILMINGTON, Del.--(BUSINESS WIRE)--Naarmate bedrijven in 2026 hun wereldwijde expansie versnellen, blijft compliance achter. Sterker nog: slechts 7% van de organisaties meldt volledige naleving binnen al hun wereldwijde entiteiten, zo blijkt uit een nieuw onderzoek van CSC, de toonaangevende aanbieder van oplossingen voor wereldwijd bedrijfsbeheer en compliance. CSC ondervroeg 350 bedrijfsjuristen (General Counsel) en senior juridische professionals in Europa, Noord-Amerika en de regio Azië-Pac...

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today reported financial results for its fiscal second quarter ended March 31, 2026. “Since the inception of our immunology portfolio targeting type 2 diseases, our team has worked diligently to advance highly selective inhibitors of KIT, STAT6 and MRGPRX2 designed to enable convenient or...

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today reported financial results for the first quarter ended March 31, 2026. “This was an important quarter for AN2 as we announced an exciting new program in polycythemia vera that is planned to enter Phase 2 development in the third quarter of 2026. This pr...

LIVERMORE, Calif--(BUSINESS WIRE)--McGrath RentCorp (“McGrath” or the “Company”) (Nasdaq: MGRC), a leading business-to-business rental company in North America, today announced that it has completed a $725 million credit facility with a syndicate of banks. The five-year facility matures on May 8, 2031, and replaces the Company’s existing $650 million line of credit. Bank of America, N.A. served as Joint Lead Arranger, Sole Bookrunner and Administrative Agent. U.S. Bank N.A. and Wells Fargo Bank...